2Arntz HR, Agrawal R, Wunderlich W, et al. Beneficial effects of pravas tatininitiated immediately after a coronary event(the randomized lipid-coronar y arterydisease[L-CADstudy). Am J Cardiol, 2000,86: 1293
3Kayikcioglu M, Turkoglu C, Kultursay H, et al. The short term results of conbineduse of pravastatin with thrombolytic therapy in acute myocardial inf arction in acutemyocardial infarction. Circulation. 1999, 100:1～303
4Schwartz GG, Oliver MF, Ezekowitz MD, et al. Rationale and design of m yocardialischemia reduction with aggressive cholesterol lowering (MIRACL) study that evaluatesatorvastatin in unstable angina pectoris and in non-Q-wave. Am J Cardiol, 1998, 81: 578
5Expert Panel on Detection, Evaluation, and Treatment of High Blood Cho lesterol inAdults. Executive summary of the third report of the national choles terol educationprogram expert panel on detection, evaluation, and treatment of high blood cholesterol inadults(ATP Ⅲ). JAMA, 2001, 285: 2486
6Wiesbauer F;Kaun C;Zom G.HMG-CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro:a compar-ative study using different statins[J],2002(1).
7Laufs U;Gertz K;Huang P.Atorvastatin upregulates type Ⅲ nitric oxide synthase in thrombocytes,decreases platelet activation,and protects from cerebral ischemia in normocholesterolemic mice,2000.
8Puccetti L;Bruni F;Bova G.Effect of diet and treatment with statins on plateletdependent thrombin generation in hypercholes-terolemic subjects,2001.
9Xu CB;Stenman E;Edvinsson L.Reduction of bFGF-induced smooth muscle cell proliferation and endothelin receptor mRNA expression by mevastatin and atorvastatin[J],2002(03).
